Synairgen (LON:SNG) Stock Price Down 21.8% – Here’s What Happened

Synairgen plc (LON:SNG) shares fell 21.8% during trading on Tuesday . The company traded as low as GBX 1.50 ($0.02) and last traded at GBX 1.56 ($0.02). 1,699,487 shares were traded during trading, an increase of 35% from the average session volume of 1,260,652 shares. The stock had previously closed at GBX 2 ($0.03).

Synairgen Price Performance

The stock has a 50-day moving average price of GBX 2.09 and a 200 day moving average price of GBX 3.37. The firm has a market cap of £13.93 million, a price-to-earnings ratio of -0.86 and a beta of -2.23.

Synairgen Company Profile

Synairgen is a respiratory drug discovery and development company founded by University of Southampton Professors Stephen Holgate, Donna Davies and Ratko Djukanovic. The business, focused primarily on lung viral defence in asthma and COPD, uses its differentiating human biology BioBank platform and world-renowned international academic KOL network to discover and develop novel therapies for respiratory disease.

Synairgen is conducting a double blind, placebo-controlled clinical trial in COVID-19 patients (SG016).